Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (18,749,163)	$ (7,640,806)
Loss from discontinued operations and disposal	(3,854,599)	0
Loss from continuing operations	(14,894,564)	(7,640,806)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	359,654	218,660
Bad debt provision	0	42,057
Amortization of debt discount	176,000	1,190,633
Stock based compensation	3,793,555	709,000
Non-cash interest expense	696,013	0
Changes in operating assets and liabilities:
Accounts receivable	(107,967)	(168,006)
Prepaid expenses and other current assets	(208,349)	(32,915)
Accounts payable and accrued expenses	460,829	1,172,306
Accrued interest	0	135,715
Deferred income	16,767	155,157
NET CASH USED IN OPERATING ACTIVITIES - CONTINUING OPERATIONS	(9,708,097)	(4,218,199)
NET CASH USED IN OPERATING ACTIVITIES - DISCONTINUED OPERATIONS	(858,821)	0
NET CASH USED IN OPERATING ACTIVITIES	(10,566,918)	(4,218,199)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(43,109)	(6,600)
Capitalization of software costs	(419,892)	(251,324)
Cash received upon acquisition	4,947,023	0
Proceeds from sale of component, net of cash relinquished	1,995,634	0
Increase in other assets	(525)	0
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES - CONTINUING OPERATIONS	6,479,131	(257,924)
NET CASH USED IN INVESTING ACTIVITIES - DISCONTINUED OPERATIONS	(33,576)	0
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	6,445,555	(257,924)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the sale of common stock	300,000	0
Proceeds from the sale of Series H-4 preferred stock and warrants	6,000,000	0
Financing costs from the sale of Series H-4 preferred stock and warrants	(101,661)	0
Proceeds from issuance of common stock in connection with exercise of H-4 warrants	936,423	0
Proceeds from the sale of Series K Warrants	983,333	0
Financing costs from the sale of Series K warrants	(15,000)	0
Proceeds from issuance of Series A Preferred Stock and subscription receivable	0	219,968
Proceeds from issuance of convertible notes and warrants	0	4,840,000
Offering costs - Convertible Notes	0	(263,200)
NET CASH PROVIDED BY FINANCING ACTIVITIES - CONTINUING OPERATIONS	8,103,095	4,796,768
NET CASH USED IN FINANCING ACTIVITIES - DISCONTINUED OPERATIONS	(50,263)	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	8,052,832	4,796,768
Net increase in cash	3,931,469	320,645
Cash, beginning of period	372,011	51,366
Cash, end of period	4,303,480	372,011
NON-CASH FINANCING ACTIVITIES:
Fair value of stock warrants issued with convertible notes	0	2,138,931
Fair value of common stock sold to founders	0	684,000
Accrued offering costs	0	122,000
Accrued capitalized software costs	0	108,979
Stock issued to WPCS Shareholder in the merger net of cash received of $4,947,023	4,845,200	0
Liabilities assumed in connection with the sale of component	568,468	0
Series H-4 offering cost paid in H-4 shares and warrants	3,682,502	0
Stock issued for convertible note payable	159,584	0
Stock issued for accrued interest on convertible note payable	1,399,656	0
Deemed dividends on warrant issuances and modification	$ 1,399,632	$ 0